Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fiserv Inc
FISV
|
+$1.28B |
| 2 |
Aon
AON
|
+$1.25B |
| 3 |
Willis Towers Watson
WTW
|
+$762M |
| 4 |
Fidelity National Information Services
FIS
|
+$571M |
| 5 |
Adobe
ADBE
|
+$565M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$962M |
| 2 |
Goldman Sachs
GS
|
+$814M |
| 3 |
GE Aerospace
GE
|
+$764M |
| 4 |
Nutrien
NTR
|
+$587M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.72% |
| 2 | Financials | 18.28% |
| 3 | Industrials | 12.84% |
| 4 | Technology | 11.99% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Alphabet (Google) Class A
GOOGL
$4.33T
| $2.76B | 1.49% |
11,338,777
+63,559
| +0.6% | +$13.3M |
2015 Q4
39 quarters
|
|
27
Cigna
CI
$74.8B
| $2.68B | 1.45% |
9,305,225
+354,615
| +4% | +$105M |
2013 Q2
49 quarters
|
|
28
Capital One
COF
$124B
| $2.57B | 1.39% |
12,107,917
-748,539
| -6% | -$164M |
2013 Q2
49 quarters
|
|
29
Regeneron Pharmaceuticals
REGN
$78.8B
| $2.56B | 1.38% |
4,550,845
+724,562
| +19% | +$410M |
2021 Q4
15 quarters
|
|
30
Air Products & Chemicals
APD
$63.5B
| $2.46B | 1.33% |
9,004,892
+183,492
| +2% | +$53.1M |
2013 Q2
49 quarters
|
|
31
Zimmer Biomet
ZBH
$17.5B
| $2.29B | 1.23% |
23,216,173
+1,118,710
| +5% | +$111M |
2022 Q1
14 quarters
|
|
32
International Flavors & Fragrances
IFF
$21.6B
| $2.28B | 1.23% |
36,972,638
+1,925,251
| +5% | +$132M |
2023 Q4
7 quarters
|
|
33
AB InBev
BUD
$154B
| $2.18B | 1.18% |
36,546,221
-1,931,321
| -5% | -$122M |
2021 Q4
15 quarters
|
|
34
Baker Hughes
BKR
$56.1B
| $2.15B | 1.16% |
44,053,488
-529,325
| -1% | -$23.4M |
2017 Q3
32 quarters
|
|
35
Fortive
FTV
$17.5B
| $2.09B | 1.13% |
42,595,794
+9,422,189
| +28% | +$464M |
2024 Q4
3 quarters
|
|
36
GE HealthCare
GEHC
$30.6B
| $2.07B | 1.12% |
27,517,311
+3,949,361
| +17% | +$295M |
2023 Q1
10 quarters
|
|
37
Alibaba
BABA
$275B
| $1.96B | 1.06% |
10,975,370
+11,100
| +0.1% | +$1.45M |
2018 Q4
27 quarters
|
|
|
38
GE Aerospace
GE
$323B
| $1.89B | 1.02% |
6,271,622
-2,794,189
| -31% | -$764M |
2013 Q2
49 quarters
|
|
39
SBA Communications
SBAC
$19.4B
| $1.87B | 1.01% |
9,667,297
+1,058,803
| +12% | +$229M |
2024 Q3
4 quarters
|
|
40
Sun Communities
SUI
$13.9B
| $1.87B | 1.01% |
14,480,815
+282,055
| +2% | +$35.6M |
2024 Q1
6 quarters
|
|
|
41
Goldman Sachs
GS
$260B
| $1.76B | 0.95% |
2,208,625
-1,097,949
| -33% | -$814M |
2013 Q2
49 quarters
|
|
42
UBS Group
UBS
$147B
| $1.75B | 0.95% |
42,641,442
-2,994,500
| -7% | -$116M |
2018 Q3
28 quarters
|
|
43
Elanco Animal Health
ELAN
$11.4B
| $1.67B | 0.9% |
82,759,837
-135,395
| -0.2% | -$2.27M |
2021 Q3
16 quarters
|
|
44
Coupang
CPNG
$27.5B
| $1.51B | 0.82% |
46,947,720
+333,200
| +0.7% | +$10.1M |
2024 Q2
5 quarters
|
|
45
Avantor
AVTR
$10.5B
| $1.47B | 0.79% |
117,746,888
+313,404
| +0.3% | +$4.04M |
2023 Q3
8 quarters
|
|
46
Dominion Energy
D
$54.9B
| $1.39B | 0.75% |
22,780,033
-145,215
| -0.6% | -$8.63M |
2023 Q1
10 quarters
|
|
47
Haleon
HLN
$41.6B
| $1.38B | 0.75% |
154,384,622
-1,087,377
| -0.7% | -$10.5M |
2022 Q3
12 quarters
|
|
48
Novartis
NVS
$273B
| $1.36B | 0.73% |
10,585,145
-62,484
| -0.6% | -$7.62M |
2013 Q2
49 quarters
|
|
49
Baxter International
BAX
$12.7B
| $1.31B | 0.71% |
57,396,370
+5,274,750
| +10% | +$134M |
2023 Q3
8 quarters
|
|
50
Credicorp
BAP
$30.5B
| $1.3B | 0.7% |
4,899,715
-247,665
| -5% | -$61.3M |
2020 Q3
20 quarters
|
|
Similar funds
Dodge & Cox's Q3 2025 Portfolio in Review
As of Q3 2025, Dodge & Cox held 225 positions worth $185B, up 4.1% from $178B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Dodge & Cox's Q3 2025 filing shows 6 new, 50 increased, 106 reduced and 6 closed positions. Its largest new stake was Aon: 3,464,683 shares worth $1.24B. The largest sale was Wells Fargo, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Dodge & Cox's largest Q3 2025 buy was Aon: 3,464,683 shares worth $1.24B.
- Dodge & Cox added most to Fiserv Inc in Q3 2025, an estimated $1.28B increase.
- Dodge & Cox's biggest Q3 2025 reduction was Wells Fargo, cutting an estimated $962M.
- Dodge & Cox fully exited Nutrien in Q3 2025, selling an estimated $587M.
- Dodge & Cox's ten largest holdings make up 28% of its $185B portfolio in Q3 2025.
- Dodge & Cox opened 6 new positions and closed 6 in Q3 2025.
- Dodge & Cox's portfolio value rose 4.1% quarter-over-quarter to $185B.
Based on Dodge & Cox's 13F filing for Q3 2025, filed 13 Nov 2025.